4//SEC Filing
Bozigian Haig P. 4
Accession 0001209191-20-058539
CIK 0000914475other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 6:08 PM ET
Size
5.6 KB
Accession
0001209191-20-058539
Insider Transaction Report
Form 4
Bozigian Haig P.
Sr Vice President, Development
Transactions
- Sale
Common Stock
2020-11-12$90.74/sh−2,257$204,806→ 152,694 total
Footnotes (2)
- [F1]Sale of 2,257 shares of common stock issued upon vesting of 4,288 performance restricted stock units to cover withholding taxes, with the balance of the shares (2,031) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $88.93 to $92.23. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
Related Parties
1- filerCIK 0001423837
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 6:08 PM ET
- Size
- 5.6 KB